ANDA 91374, held by Am Regent. Desmopressin Acetate.
As of Nov 16, 2026, ANDA 91374 (Desmopressin Acetate), held by Am Regent, was first approved by FDA on Feb 14, 2019, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 14, 2019 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Desmopressin Acetate0.004MG/ML ยท injectable;injection | Desmopressin Acetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters